<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>82</volume><submitter>Zamora V</submitter><pubmed_abstract>&lt;h4>Background and objective&lt;/h4>Our objective was to compare the impact of open radical prostatectomy (RP), external beam radiotherapy (EBRT), and brachytherapy in patients with localized prostate cancer via patient-reported outcome measures up to 20 yr after treatment.&lt;h4>Methods&lt;/h4>This was a prospective observational study (ClinicalTrials.gov NCT01492751) of men with localized prostate cancer (clinical stage T1-T2, low or intermediate risk). The Expanded Prostate Cancer Index Composite (EPIC-26) and Short Form-36 (SF-36) questionnaires were centrally administered via telephone interviews before treatment and then annually after treatment. Generalized estimating equation models were constructed with propensity score-based weights.&lt;h4>Key findings and limitations&lt;/h4>The RP group report</pubmed_abstract><journal>European urology open science</journal><pagination>160-167</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12648591</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Twenty-year Patient-reported Outcomes After Surgery, Radiotherapy, or Brachytherapy for Localized Prostate Cancer.</pubmed_title><pmcid>PMC12648591</pmcid><pubmed_authors>Ventura M</pubmed_authors><pubmed_authors>Sancho G</pubmed_authors><pubmed_authors>Bonet X</pubmed_authors><pubmed_authors>Alonso J</pubmed_authors><pubmed_authors>de Paula B</pubmed_authors><pubmed_authors>Ortiz MJ</pubmed_authors><pubmed_authors>Suarez JF</pubmed_authors><pubmed_authors>Goni A</pubmed_authors><pubmed_authors>Garin O</pubmed_authors><pubmed_authors>Ferrer F</pubmed_authors><pubmed_authors>Pont A</pubmed_authors><pubmed_authors>Palou J</pubmed_authors><pubmed_authors>Herruzo I</pubmed_authors><pubmed_authors>de Leon JP</pubmed_authors><pubmed_authors>Guedea F</pubmed_authors><pubmed_authors>Cabrera P</pubmed_authors><pubmed_authors>Avila M</pubmed_authors><pubmed_authors>Macias V</pubmed_authors><pubmed_authors>Fernandez P</pubmed_authors><pubmed_authors>Ferrer M</pubmed_authors><pubmed_authors>Ponce de Leon J</pubmed_authors><pubmed_authors>Castells M</pubmed_authors><pubmed_authors>Pastor S</pubmed_authors><pubmed_authors>Gutierrez C</pubmed_authors><pubmed_authors>Pardo Y</pubmed_authors><pubmed_authors>Hervas A</pubmed_authors><pubmed_authors>Multicenter Spanish Group for Clinically Localized Prostate Cancer</pubmed_authors><pubmed_authors>Sole J</pubmed_authors><pubmed_authors>Bonet C</pubmed_authors><pubmed_authors>Marino A</pubmed_authors><pubmed_authors>Zamora V</pubmed_authors><pubmed_authors>Boladeras A</pubmed_authors><pubmed_authors>Ramos A</pubmed_authors><pubmed_authors>Bonet M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Twenty-year Patient-reported Outcomes After Surgery, Radiotherapy, or Brachytherapy for Localized Prostate Cancer.</name><description>&lt;h4>Background and objective&lt;/h4>Our objective was to compare the impact of open radical prostatectomy (RP), external beam radiotherapy (EBRT), and brachytherapy in patients with localized prostate cancer via patient-reported outcome measures up to 20 yr after treatment.&lt;h4>Methods&lt;/h4>This was a prospective observational study (ClinicalTrials.gov NCT01492751) of men with localized prostate cancer (clinical stage T1-T2, low or intermediate risk). The Expanded Prostate Cancer Index Composite (EPIC-26) and Short Form-36 (SF-36) questionnaires were centrally administered via telephone interviews before treatment and then annually after treatment. Generalized estimating equation models were constructed with propensity score-based weights.&lt;h4>Key findings and limitations&lt;/h4>The RP group report</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-05T18:46:38.891Z</modification><creation>2026-05-20T03:13:22.796Z</creation></dates><accession>S-EPMC12648591</accession><cross_references><pubmed>41311640</pubmed><doi>10.1016/j.euros.2025.10.007</doi></cross_references></HashMap>